Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy

References

• HeoMBChoMYLimYTPolymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cellsActa Biomater20141052169217624394635
   PubMed Web of Science ®Google Scholar
• HubbellJAThomasSNSwartzMAMaterials engineering for immunomodulationNature2009462727244946019940915
   PubMed Web of Science ®Google Scholar
• SteinmanRMDendritic cells in vivo: a key target for a new vaccine scienceImmunity200829331932418799140
   PubMedGoogle Scholar
• GelaoLCriscitielloCEspositoADendritic cell-based vaccines: clinical applications in breast cancerImmunotherapy20146334936024762078
   PubMed Web of Science ®Google Scholar
• ChiangCLBalintKCoukosGKandalaftLEPotential approaches for more successful dendritic cell-based immunotherapyExpert Opin Biol Ther201515456958225553913
   PubMed Web of Science ®Google Scholar
• CruzLJRosaliaRAKleinovinkJWRuedaFLowikCWOssendorpFTargeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative studyJ Control Release201419220921825068703
   PubMed Web of Science ®Google Scholar
• ReddySTSwartzMAHubbellJATargeting dendritic cells with biomaterials: developing the next generation of vaccinesTrends Immunol2006271257357917049307
   PubMed Web of Science ®Google Scholar
• RosaliaRASilvaALCampsMEfficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticlesCancer Immunol Immunother20136271161117323613147
   PubMedGoogle Scholar
• LiuSYWeiWYueHNanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapyBiomaterials201334338291830023910466
   PubMed Web of Science ®Google Scholar
• FeliceBPrabhakaranMPRodriguezAPRamakrishnaSDrug delivery vehicles on a nano-engineering perspectiveMater Sci Eng C Mater Biol Appl20144117819524907751
   PubMed Web of Science ®Google Scholar
• van der MeelRVehmeijerLJKokRJStormGvan GaalEVLigand-targeted particulate nanomedicines undergoing clinical evaluation: current statusAdv Drug Deliv Rev201365101284129824018362
   PubMed Web of Science ®Google Scholar
• GodseyMESuryaprakashSLeongKWMaterials innovation for co-delivery of diverse therapeutic cargosRSC Adv2013347247942481124818000
   PubMedGoogle Scholar
• JoshiVBGearySMSalemAKBiodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responsesHum Vaccin Immunother20139122584259023978910
   PubMed Web of Science ®Google Scholar
• HeoMBLimYTProgrammed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cellsBiomaterials201435159060024125775
   PubMed Web of Science ®Google Scholar
• ZhangZTongchusakSMizukamiYInduction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen deliveryBiomaterials201132143666367821345488
   PubMed Web of Science ®Google Scholar
• Perez-GironJVBelicha-VillanuevaAHassanEMucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunityJ Immunol201419331324133224958904
   PubMed Web of Science ®Google Scholar
• QuinnKMYamamotoACostaACoadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunityJ Immunol2013191105085509624089189
   PubMed Web of Science ®Google Scholar
• HafnerAMCorthesyBMerkleHPParticulate formulations for the delivery of poly (I:C) as vaccine adjuvantAdv Drug Deliv Rev201365101386139923751781
   PubMed Web of Science ®Google Scholar
• YaoMHMaMChenYMultifunctional Bi2S3/PLGA nanocapsule for combined HIFU/radiation therapyBiomaterials201435288197820524973300
   PubMedGoogle Scholar
• ZhangYGouJSunFImpact of electrolytes on double emulsion systems (W/O/W) stabilized by an amphiphilic block copolymerColloids Surf B Biointerfaces201412236837425086304
   PubMedGoogle Scholar
• DolenYKreutzMGileadiUCo-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responsesOncoimmunology201551e106849326942088
   PubMedGoogle Scholar
• ZhouFCiricBZhangGXRostamiAImmunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitisClin Exp Immunol2014178344745825138204
   PubMedGoogle Scholar
• RohJWHuangJHuWBiologic effects of platelet-derived growth factor receptor alpha blockade in uterine cancerClin Cancer Res201420102740275024634380
   PubMedGoogle Scholar
• KangTHKimYSKimSPancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4Oncotarget2015629277512776226336989
   PubMedGoogle Scholar
• KangTHKnoffJYehWHTreatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effectsPLoS One201497e10356225072795
   PubMedGoogle Scholar
• JungIDShinSJLeeMGEnhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein XJ Immunol201419331233124524990079
   PubMed Web of Science ®Google Scholar
• SongCKHanHDNohKHChemotherapy enhances CD8(+) T cell-mediated antitumor immunity induced by vaccination with vaccinia virusMol Ther20071581558156317551502
   PubMedGoogle Scholar
• RamakrishnanRAssudaniDNagarajSChemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in miceJ Clin Invest201012041111112420234093
   PubMed Web of Science ®Google Scholar
• ChoMSVasquezHGRupaimooleRAutocrine effects of tumor-derived complementCell Rep2014661085109524613353
   PubMed Web of Science ®Google Scholar
• CarmiYSpitzerMHLindeILAllogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunityNature201552175509910425924063
   PubMed Web of Science ®Google Scholar
• SinghMChakrapaniAO’HaganDNanoparticles and microparticles as vaccine-delivery systemsExpert Rev Vaccines20076579780817931159
   PubMed Web of Science ®Google Scholar
• ChenJPompanoRRSantiagoFWThe use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammationBiomaterials201334348776878523953841
   PubMed Web of Science ®Google Scholar
• YuXFeizpourARamirezNGGlycosphingolipid-functionalized nanoparticles recapitulate CD169-dependent HIV-1 uptake and trafficking in dendritic cellsNat Commun20145413624947940
   PubMedGoogle Scholar
• ZengBJChuanYPO’SullivanBReceptor-specific delivery of protein antigen to dendritic cells by a nanoemulsion formed using top-down non-covalent click self-assemblySmall20139223736374223606503
   PubMedGoogle Scholar
• AmmiRDe WaeleJWillemenYPoly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughsPharmacol Ther201514612013125281915
   PubMed Web of Science ®Google Scholar